Rx import markup
Executive Summary
Senate Health Committee's markup of Sen. Judd Gregg's (R-N.H.) drug importation bill (S 2493) will likely be delayed until September while Gregg assesses whether there is sufficient support for passage. Markup of the bill originally scheduled for July 21 was postponed because it coincided with the White House signing ceremony for the Project BioShield Act of 2004...
You may also be interested in...
Rx import bill
Senate is unlikely to vote on drug importation legislation this year, Health Committee Counsel Steve Irizarry says during a Food & Drug Law Institute conference July 28. Sen. Judd Gregg (R-N.H.) postponed the markup of his bill (S 2493) due to the signing of the "BioShield" legislation (1"The Pink Sheet" July 26, 2004, In Brief). There has been speculation that Gregg delayed the markup to assess whether he had sufficient support...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.